Abiraterone acetate treatment in patients with castration-resistant prostate cancer with visceral metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Abiraterone acetate treatment in patients with castration-resistant prostate cancer with visceral metastases

Published:2019-02 Issue:2 Volume:30 Page:179-185
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Facchini Gaetano,Cavaliere Carla,D’Aniello Carmine,Iovane Gelsomina,Rossetti Sabrina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference22 articles.

1. SEOM clinical guidelines for the treatment of metastatic prostate cancer;Cassinello;Clin Transl Oncol,2014

2. Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer;Attard;J Clin Oncol,2009

3. Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy;Ryan;J Clin Oncol,2010

4. Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven;Attard;J Clin Oncol,2008

5. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world outcomes for first line next-generation hormonal agents in metastatic prostate cancer: a systematic review;Future Oncology;2023-11

2. What should be the future direction of development in the field of prostate cancer with lung metastasis?;World Journal of Clinical Oncology;2023-10-24

3. Making the Case for Autophagy Inhibition as a Therapeutic Strategy in Combination with Androgen-Targeted Therapies in Prostate Cancer;Cancers;2023-10-18

4. Synthesis and Antiproliferative Activity of New Copper, Cobalt, and Zinc Complexes with Abiraterone Acetate;Russian Journal of Coordination Chemistry;2023-09

5. Observation of Serological Index and Efficacy of Abiraterone Hydrochloride Tablets Combined with Endocrine Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer;Archivos Españoles de Urología;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3